Similar articles

• [Recent progress in fibrinolytic mechanism].

  Yasukouchi T. Yasukouchi T. Rinsho Byori. 1986 Mar;34(3):235-46. Rinsho Byori. 1986. PMID: 3086600 Review. Japanese. No abstract available.
• [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].

  Veremeenko KN, Kizim AI. Veremeenko KN, et al. Vopr Med Khim. 1984 Sep-Oct;30(5):13-22. Vopr Med Khim. 1984. PMID: 6084892 Review. Russian.
• [Blood coagulation mechanism from the viewpoint of molecular biochemistry].

  Hashimoto S, Asai K. Hashimoto S, et al. Rinsho Byori. 1985 Sep;33(9):957-9. Rinsho Byori. 1985. PMID: 2934563 Japanese. No abstract available.
• A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.

  Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH. Leebeek FW, et al. Gastroenterology. 1991 Nov;101(5):1382-90. doi: 10.1016/0016-5085(91)90092-y. Gastroenterology. 1991. PMID: 1718809
• [Enzymatic fibrinolytic agents].

  Jamet M, Granthil C, Levy G. Jamet M, et al. Ann Anesthesiol Fr. 1978;19(8):693-6. Ann Anesthesiol Fr. 1978. PMID: 31112 French.